| Financial Year |
March 31 2023 |
| Monetary Funds |
3,240,329,201.90 |
| Held-for-trading Financial Assets |
1,264,093,268.02 |
| Notes Receivable |
-- |
| Accounts Receivable |
7,820,972,489.30 |
| Advances to Suppliers |
268,436,125.56 |
| Other Receivables |
116,441,828.57 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
6,310,145.60 |
| Inventories |
10,778,529.13 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
185,292,834.49 |
| Total Current Assets |
13,136,921,046.85 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,853,734,373.18 |
| Investment Properties |
-- |
| Fixed Assetes |
98,034,670.42 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
15,885,083.02 |
| R&D expenses |
-- |
| Goodwill |
1,756,190,579.97 |
| Long-Term Deferred and Prepaid Expenses |
6,158,829.66 |
| Deferred Income Tax Assets |
385,516,302.03 |
| Other Non-Current Assets |
24,929,495.14 |
| Sub-Total of Non-Current Assets |
5,086,215,012.57 |
| Total Assets |
18,223,136,059.42 |
| Short-Term Loans |
1,554,526,745.69 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
7,339,290,833.49 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
191,270,187.67 |
| Taxes Payable |
149,625,112.53 |
| Interest Payable |
-- |
| Dividend Payable |
14,335,729.17 |
| Other payables |
69,542,634.14 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
26,123,200.98 |
| Other Current Liabilities |
9,795,248.23 |
| Sub-Total of Current Liabilities |
9,828,901,913.30 |
| Long-term Loans |
715,633,742.11 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
17,285,145.28 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
156,474,458.56 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
912,172,069.01 |
| Total Liabilities |
10,741,073,982.31 |
| Paid-In Capital(Or Share Stock) |
2,491,037,834.00 |
| Capital Surplus |
3,472,641,609.98 |
| Surplus Reserve |
362,099,240.45 |
| LESS:Treasury Stock |
19,889,701.89 |
| Undistributed Profits |
1,425,898,627.66 |
| Minority Stockholder's Interest |
-7,336,498.84 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,489,398,575.95 |
| Owner's Equity（Stockholder's Equity） |
7,482,062,077.11 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
18,223,136,059.42 |
